NDC 27241-270 – Tofacitinib
Tofacitinib Citrate 11 mg/1 · Tablet, Extended Release · Oral
Product NDC27241-270
Product details
- Brand name
- Tofacitinib
- Generic name
- Tofacitinib
- Labeler
- Ajanta Pharma USA Inc.
- Dosage form
- Tablet, Extended Release
- Route
- Oral
- Marketing category
- ANDA · ANDA219542
- Marketed since
- June 3, 2026
- Listing expires
- December 31, 2027
- Pharmacologic class
- Janus Kinase Inhibitor
Active ingredients
- Tofacitinib Citrate 11 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 27241-270-30 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (27241-270-30) | Jun 3, 2026 |
Other Tofacitinib products
- 59651-685 Tofacitinib Citrate 11 mg/1 · Tablet, Extended Release · Aurobindo Pharma Limited
- 60505-4858 Tofacitinib Citrate 11 mg/1 · Tablet, Film Coated, Extended Release · Apotex Corp.
- 60505-6263 Tofacitinib 5 mg/1 · Tablet, Film Coated · Apotex Corp.
- 60505-6264 Tofacitinib 10 mg/1 · Tablet, Film Coated · Apotex Corp.
- 59651-459 Tofacitinib Citrate 5 mg/1 · Tablet, Film Coated · Aurobindo Pharma Limited
- 59651-460 Tofacitinib Citrate 10 mg/1 · Tablet, Film Coated · Aurobindo Pharma Limited
- 73190-100 Tofacitinib Citrate 5 mg/1 · Tablet, Film Coated · AvKARE
- 73190-101 Tofacitinib Citrate 10 mg/1 · Tablet, Film Coated · AvKARE
- 73190-102 Tofacitinib Citrate 11 mg/1 · Tablet, Film Coated, Extended Release · AvKARE
- 70377-057 Tofacitinib Citrate 11 mg/1 · Tablet, Film Coated, Extended Release · Biocon Pharma Inc
- 51991-329 Tofacitinib Citrate 5 mg/1 · Tablet · Breckenridge Pharmaceutical, Inc.
- 51991-963 Tofacitinib Citrate 10 mg/1 · Tablet · Breckenridge Pharmaceutical, Inc.